Encompass Health Co. (NYSE:EHC) Shares Sold by Wedge Capital Management L L P NC

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

Wedge Capital Management L L P NC lessened its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 7.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 194,913 shares of the company's stock after selling 15,775 shares during the period. Wedge Capital Management L L P NC owned approximately 0.19% of Encompass Health worth $13,005,000 as of its most recent SEC filing.

Other institutional investors have also modified their holdings of the company. McGlone Suttner Wealth Management Inc. purchased a new position in Encompass Health in the fourth quarter valued at $30,000. C M Bidwell & Associates Ltd. acquired a new position in shares of Encompass Health during the third quarter worth about $35,000. Harvest Fund Management Co. Ltd purchased a new stake in shares of Encompass Health during the third quarter worth approximately $109,000. Acadian Asset Management LLC acquired a new stake in Encompass Health in the third quarter valued at approximately $111,000. Finally, EverSource Wealth Advisors LLC lifted its stake in Encompass Health by 14.7% in the third quarter. EverSource Wealth Advisors LLC now owns 2,713 shares of the company's stock worth $182,000 after acquiring an additional 347 shares during the last quarter. Institutional investors and hedge funds own 97.25% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on the stock. Royal Bank of Canada restated an "outperform" rating and issued a $83.00 price objective on shares of Encompass Health in a report on Friday, February 9th. Barclays increased their price objective on Encompass Health from $95.00 to $101.00 and gave the company an "overweight" rating in a report on Thursday, March 28th. Truist Financial boosted their target price on Encompass Health from $82.00 to $86.00 and gave the stock a "buy" rating in a research note on Friday, February 9th. Stephens reissued an "overweight" rating and set a $85.00 price objective on shares of Encompass Health in a report on Tuesday, January 16th. Finally, William Blair restated an "outperform" rating on shares of Encompass Health in a report on Wednesday, February 7th. Eight research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Buy" and a consensus target price of $83.22.


Get Our Latest Research Report on Encompass Health

Encompass Health Stock Performance

NYSE EHC traded up $2.13 during trading on Tuesday, reaching $82.46. The company's stock had a trading volume of 695,644 shares, compared to its average volume of 654,462. The business's fifty day moving average price is $77.70 and its 200-day moving average price is $70.59. Encompass Health Co. has a twelve month low of $57.55 and a twelve month high of $83.73. The company has a debt-to-equity ratio of 1.19, a quick ratio of 1.28 and a current ratio of 1.28. The firm has a market cap of $8.26 billion, a price-to-earnings ratio of 23.76, a P/E/G ratio of 1.47 and a beta of 0.94.

Encompass Health (NYSE:EHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported $0.95 EPS for the quarter, beating the consensus estimate of $0.83 by $0.12. Encompass Health had a return on equity of 17.69% and a net margin of 7.33%. The firm had revenue of $1.25 billion during the quarter, compared to the consensus estimate of $1.24 billion. As a group, analysts anticipate that Encompass Health Co. will post 3.96 EPS for the current fiscal year.

Encompass Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, April 15th. Stockholders of record on Monday, April 1st were paid a $0.15 dividend. This represents a $0.60 annualized dividend and a dividend yield of 0.73%. The ex-dividend date was Thursday, March 28th. Encompass Health's dividend payout ratio (DPR) is presently 17.29%.

About Encompass Health

(Free Report)

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.

Read More

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Should you invest $1,000 in Encompass Health right now?

Before you consider Encompass Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Encompass Health wasn't on the list.

While Encompass Health currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Featured Articles and Offers

Search Headlines: